EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Cancer Epitope Database and Analysis Resource (CEDAR)

Zeynep Koşaloğlu-Yalçın iD, Nina Blazeska, Randi Vita, Hannah Carter, Morten Nielsen iD, Stephen Schoenberger, Alessandro Sette, Bjoern Peters

Nucleic Acids Research · 06.01.2023 · 51 (D1) · D845-D852

DOI: 10.1093/nar/gkac902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nucleic Acids Research, online erschienen am 17.10.2022. Verfasst von Zeynep Koşaloğlu-Yalçın und 7 weiteren Autor:innen. Beteiligte Einrichtung: Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA. Hauptthemen laut MEDLINE: Epitopes, Antigens, Neoplasm, Databases, Chemical. Die Arbeit wurde bisher 78-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIDCR NIH HHS, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We established The Cancer Epitope Database and Analysis Resource (CEDAR) to catalog all epitope data in the context of cancer. The specific molecular targets of adaptive T cell and B cell immune responses are referred to as epitopes. Epitopes derived from cancer antigens are of high relevance as they are recognized by anti-cancer immune cells. Detailed knowledge of the molecular characteristic of cancer epitopes and associated metadata is relevant to understanding and planning prophylactic and therapeutic applications and accurately characterizing naturally occurring immune responses and cancer immunopathology. CEDAR provides a freely accessible, comprehensive collection of cancer epitope and receptor data curated from the literature and serves as a companion site to the Immune Epitope Database (IEDB), which is focused on infectious, autoimmune, and allergic diseases. CEDAR is freely accessible at https://cedar.iedb.org/.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EpitopesAntigens, NeoplasmDatabases, ChemicalHumansData ManagementDatabases, Protein

Substanzen

EpitopesAntigens, Neoplasm

Autor:innen und Institutionen

  • Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA, USA.
  • Department of Medicine, University of California San Diego, La Jolla, CA, USA.
  • Department of Bio and Health Informatics, Technical University of Denmark, Lyngby, Denmark.
  • Instituto de Investigaciones Biotecnológicas, Universidad Nacional de San Martín, San Martín, Argentina.
  • Laboratory of Cellular Immunology, La Jolla Institute for Immunology, La Jolla, CA, USA.

ORCID-Profile: Zeynep Koşaloğlu-Yalçın, Morten Nielsen

Förderung

  • NIAID NIH HHS
  • NIDCR NIH HHS
  • NCI NIH HHS
  • National Institutes of Health

Zitieren

APA

Koşaloğlu-Yalçın, Z., Blazeska, N., Vita, R., Carter, H., Nielsen, M., Schoenberger, S., Sette, A., & Peters, B. (2023). The Cancer Epitope Database and Analysis Resource (CEDAR). Nucleic Acids Research, 51(D1), D845-D852. https://doi.org/10.1093/nar/gkac902

Vancouver

Koşaloğlu-Yalçın Z, Blazeska N, Vita R, Carter H, Nielsen M, Schoenberger S, et al. The Cancer Epitope Database and Analysis Resource (CEDAR). Nucleic Acids Research. 2023;51(D1):D845-D852. doi:10.1093/nar/gkac902

BibTeX
@article{KoaloluYaln2023,
  author = {Koşaloğlu-Yalçın, Zeynep and Blazeska, Nina and Vita, Randi and Carter, Hannah and Nielsen, Morten and Schoenberger, Stephen and Sette, Alessandro and Peters, Bjoern},
  title = {The Cancer Epitope Database and Analysis Resource (CEDAR)},
  journal = {Nucleic Acids Research},
  year = {2023},
  volume = {51},
  number = {D1},
  pages = {D845--D852},
  doi = {10.1093/nar/gkac902}
}
Kostenlos starten →